RTP801 mediates transneuronal toxicity in culture via extracellular vesicles

Júlia Solana-Balaguer1,2,3, Núria Martín-Flores1,2, Pol Garcia-Segura1,2,3

  • 1Department of Biomedical Sciences, Universitat de Barcelona, Barcelona, Spain.

PubMed

Insights

Toxicity from the RTP801 protein can spread between neurons through extracellular vesicles (EVs), contributing to neurodegeneration. Silencing RTP801 in EVs protected neurons and maintained essential signaling pathways.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Extracellular vesicles (EVs) mediate intercellular communication, transferring molecules between cells.
  • RTP801 is a stress-induced protein linked to neurodegeneration and neuronal death.
  • The trans-neuronal transfer of RTP801 toxicity via EVs is not well understood.

Purpose of the Study:

  • To investigate whether RTP801 toxicity is transferred between neurons via EVs.
  • To determine the role of RTP801 in the proteomic signature and function of neuron-derived EVs.
  • To assess the impact of RTP801-carrying EVs on neuronal apoptosis and morphology.

Main Methods:

  • Overexpression and silencing of RTP801 in cultured cortical neurons.
  • Isolation and mass spectrometry-based proteomic characterization of neuron-derived EVs.
  • Treatment of recipient neurons with engineered EVs and assessment of apoptosis, morphology, and signaling pathways (mTOR/Akt).
  • Utilizing a 6-Hydroxydopamine (6-OHDA) in vitro model of neurodegeneration.

Main Results:

  • RTP801 overexpression increased EV release and altered EV proteomic content, including pro-apoptotic markers.
  • RTP801-containing EVs induced apoptosis and reduced neuronal branching, confirming trans-neuronal toxicity transfer.
  • EVs from RTP801-silenced neurons (shRTP801-EVs) promoted neuronal arborization.
  • 6-OHDA treatment increased RTP801 in EVs and impaired Akt/RPS6 signaling; this impairment was rescued by shRTP801-EVs.

Conclusions:

  • RTP801 toxicity is transferable between neurons via EVs, contributing to neurodegenerative processes.
  • EVs carrying RTP801 can propagate neuronal damage and disrupt critical signaling pathways.
  • Targeting RTP801 within EVs may offer a therapeutic strategy for neurodegenerative diseases.